Five Topics That Shaped Japan Pharma In 2019
Strategic Corporate Moves Dominate
Executive Summary
Looking back on the top stories about Japan in Scrip and the Pink Sheet over 2019, it is hard to avoid the continued dominance of corporate transactions - in particular those involving Takeda.